{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:09:38Z","timestamp":1791454178153,"version":"4.3.3"},"reference-count":33,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Investissement d\u2019Avenir","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2021-03118"],"award-info":[{"award-number":["2021-03118"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2025-03261"],"award-info":[{"award-number":["2025-03261"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017337","name":"Institut Imagine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017337","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European","award":["ANR-22-CE17-0040"],"award-info":[{"award-number":["ANR-22-CE17-0040"]}]},{"name":"European","award":["ERC-2013-AdG-339407-IMMUNOBIOTA"],"award-info":[{"award-number":["ERC-2013-AdG-339407-IMMUNOBIOTA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,6,24]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoantibodies neutralising interleukin-10 (IL-10) have recently been described as a mechanism of inflammatory bowel disease (IBD); however, prevalence and clinical impacts are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the prevalence and longitudinal persistence of IL-10 autoantibodies in a population of paediatric-onset IBD and to assess associated clinical features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We analysed plasma IL-10 autoantibodies with a cross-sectional study of a paediatric cohort of patients diagnosed with either IBD (n=239), autoimmune enteropathy (n=37) or congenital diarrhoea and enteropathies (n=42). Functional testing to assess IL-10 response was performed using cell-based assays under biologically relevant stimulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five patients with autoantibodies neutralising 2.5\u2009ng\/mL of IL-10 were identified, three of whom were also neutralising at 5\u2009ng\/mL. All had IBD without a known monogenic cause. Longitudinal samples (available in three of five subjects) showed autoantibody persistence in two cases, 3 and 9 years after baseline. The patient without persistence had undergone haematopoietic stem-cell transplantation (HSCT) 2 years after baseline sampling. The prevalence of neutralising IL-10 autoantibodies was 2.1% (95% CI 0.7% to 4.8%), while the frequency was 2.6% in subjects without IBD-associated monogenic variants (n=192).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In paediatric autoimmune and inflammatory gut diseases, IL-10 neutralising autoantibodies were detected only among patients with IBD without known genetic aetiology. Patients had heterogeneous clinical characteristics and IL-10 autoantibodies persisted under standard immunosuppressive treatment but disappeared following HSCT and may have declined with colectomy or ileostomy. Screening for IL-10 autoantibodies via functional assays may identify a subgroup of patients with distinct aetiology and therapeutic needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2026-338876","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:20:26Z","timestamp":1783531226000},"page":"gutjnl-2026-338876","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["IL-10-neutralising autoantibodies in paediatric-onset inflammatory bowel disease"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-3330","authenticated-orcid":false,"given":"Ahmet","family":"Yalcinkaya","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden"},{"name":"Science for Life Laboratory (SciLifeLab), Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden"},{"name":"Science for Life Laboratory (SciLifeLab), Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J","family":"Degrace","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden"},{"name":"Science for Life Laboratory (SciLifeLab), Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Pigneur","sequence":"additional","affiliation":[{"name":"Universite Paris Cite, Paris, France"},{"name":"Department of Pediatric Gastroenterology, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Abi-Nader","sequence":"additional","affiliation":[{"name":"Universite Paris Cite, Paris, France"},{"name":"Department of Pediatric Gastroenterology, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominque","family":"Berrebi","sequence":"additional","affiliation":[{"name":"Universite Paris Cite, Paris, France"},{"name":"Tissue Immunity in Homeostasis and Disease, Inserm UMR1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Duclaux-Loras","sequence":"additional","affiliation":[{"name":"International Center for Research in Infectiology, UMR5308, Lyon, France"},{"name":"Department of Pediatric Gastroenterology, Hepatology and Nutrition, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Nancey","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, H\u00f4pital Lyon Sud, Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Collardeau-Frachon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-6247","authenticated-orcid":false,"given":"Jean-Marc","family":"Gornet","sequence":"additional","affiliation":[{"name":"Universite Paris Cite, Paris, France"},{"name":"Department of Gastroenterology, Assistance Publique - Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bertheau","sequence":"additional","affiliation":[{"name":"Universite Paris Cite, Paris, France"},{"name":"Department of Pathology, Assistance Publique - Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Mar","family":"Tolin Hernani","sequence":"additional","affiliation":[{"name":"Digestive, Hepatology and Paediatric Nutrition Unit, Infant Maternal Hospital, Hospital General Universitario Gregorio Maranon, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dumaine","sequence":"additional","affiliation":[{"name":"Tissue Immunity in Homeostasis and Disease, Inserm UMR1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bana","family":"Jabri","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"},{"name":"Tissue Immunity in Homeostasis and Disease, Inserm UMR1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M","family":"Ruemmele","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"},{"name":"Tissue Immunity in Homeostasis and Disease, Inserm UMR1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-1245","authenticated-orcid":false,"given":"Nadine","family":"Cerf-Bensussan","sequence":"additional","affiliation":[{"name":"Intestinal Immunity, Inserm UMR1163, Paris, France"},{"name":"Genomic Medicine for Rare Diseases, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Parlato","sequence":"additional","affiliation":[{"name":"Tissue Immunity in Homeostasis and Disease, Inserm UMR1163, Paris, France"},{"name":"Intestinal Immunity, Inserm UMR1163, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Charbit-Henrion","sequence":"additional","affiliation":[{"name":"Intestinal Immunity, Inserm UMR1163, Paris, France"},{"name":"Genomic Medicine for Rare Diseases, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Landegren","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden"},{"name":"Science for Life Laboratory (SciLifeLab), Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2026070810201532000_gutjnl-2026-338876v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2002697"},{"key":"2026070810201532000_gutjnl-2026-338876v1.2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2468-1253(22)00337-5","article-title":"Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"8","author":"Kammermeier","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026070810201532000_gutjnl-2026-338876v1.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.045"},{"key":"2026070810201532000_gutjnl-2026-338876v1.4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cei\/uxac040","article-title":"The clinical, molecular, and therapeutic features of patients with IL10\/IL10R deficiency: a systematic review","volume":"208","author":"Sharifinejad","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"2026070810201532000_gutjnl-2026-338876v1.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907206"},{"key":"2026070810201532000_gutjnl-2026-338876v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.112"},{"key":"2026070810201532000_gutjnl-2026-338876v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.03.021"},{"key":"2026070810201532000_gutjnl-2026-338876v1.8","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.227","article-title":"IL-10 Receptor Neutralization-Induced Colitis in Mice: A Comprehensive Guide","volume":"1","author":"Saha","year":"2021","journal-title":"Curr Protoc"},{"key":"2026070810201532000_gutjnl-2026-338876v1.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312302"},{"key":"2026070810201532000_gutjnl-2026-338876v1.10","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-025-00979-3","article-title":"Non-celiac Enteropathies","volume":"27","author":"Mi","year":"2025","journal-title":"Curr Gastroenterol Rep"},{"key":"2026070810201532000_gutjnl-2026-338876v1.11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/ecco-jcc\/jjab056","article-title":"Inflammatory Bowel Disease in Patients with Congenital Chloride Diarrhoea","volume":"15","author":"Norsa","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2026070810201532000_gutjnl-2026-338876v1.12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa2405333","article-title":"The Genetic Architecture of Congenital Diarrhea and Enteropathy","volume":"392","author":"Gaibee","year":"2025","journal-title":"N Engl J Med"},{"key":"2026070810201532000_gutjnl-2026-338876v1.13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-024-00962-9","article-title":"Cellular and molecular basis of proximal small intestine disorders","volume":"21","author":"Bildstein","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026070810201532000_gutjnl-2026-338876v1.14","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.615216","article-title":"An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease","volume":"9","author":"Shaoul","year":"2021","journal-title":"Front Pediatr"},{"key":"2026070810201532000_gutjnl-2026-338876v1.15","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy068"},{"key":"2026070810201532000_gutjnl-2026-338876v1.16","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008301602785"},{"key":"2026070810201532000_gutjnl-2026-338876v1.17","doi-asserted-by":"publisher","DOI":"10.1159\/000277632"},{"key":"2026070810201532000_gutjnl-2026-338876v1.18","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1007\/BF02088746","article-title":"Involvement of interleukin-4 and -10 in inflammatory bowel disease","volume":"41","author":"Nielsen","year":"1996","journal-title":"Digest Dis Sci"},{"key":"2026070810201532000_gutjnl-2026-338876v1.19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2249.1995.tb03721.x","article-title":"Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD)","volume":"100","author":"Kucharzik","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2026070810201532000_gutjnl-2026-338876v1.20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.gastro.2022.05.029","article-title":"Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn\u2019s Disease","volume":"163","author":"Mortha","year":"2022","journal-title":"Gastroenterology"},{"key":"2026070810201532000_gutjnl-2026-338876v1.21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.12.042"},{"key":"2026070810201532000_gutjnl-2026-338876v1.22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.192953","article-title":"Characteristics of anti-integrin \u03b1v\u03b26 autoantibodies in patients with ulcerative colitis","volume":"11","author":"Takimoto","year":"2026","journal-title":"JCI Insight"},{"key":"2026070810201532000_gutjnl-2026-338876v1.23","doi-asserted-by":"crossref","unstructured":"Roth D , D\u00fcll MM , Horst LJ , et al . Integrin \u03b1V\u03b26: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. J Crohn's Colitis 2025;19. doi:10.1093\/ecco-jcc\/jjae131","DOI":"10.1093\/ecco-jcc\/jjae131"},{"key":"2026070810201532000_gutjnl-2026-338876v1.24","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240546","article-title":"Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitis","volume":"221","author":"Ghasempour","year":"2024","journal-title":"J Exp Med"},{"key":"2026070810201532000_gutjnl-2026-338876v1.25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2249.2008.03802.x","article-title":"Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies","volume":"155","author":"Ebert","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2026070810201532000_gutjnl-2026-338876v1.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035766"},{"key":"2026070810201532000_gutjnl-2026-338876v1.27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-336156"},{"key":"2026070810201532000_gutjnl-2026-338876v1.28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.5989","article-title":"Late Relapse After Autologous Hematopoietic Stem Cell Transplantation in AQP4-IgG-Positive NMOSD","volume":"8","author":"Vorasoot","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026070810201532000_gutjnl-2026-338876v1.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10820-2"},{"key":"2026070810201532000_gutjnl-2026-338876v1.30","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1182\/blood.V88.9.3621.bloodjournal8893621","article-title":"Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation","volume":"88","author":"Euler","year":"1996","journal-title":"Blood"},{"key":"2026070810201532000_gutjnl-2026-338876v1.31","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1532\/IJH97.06029","article-title":"Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma","volume":"84","author":"Isshiki","year":"2006","journal-title":"Int J Hematol"},{"key":"2026070810201532000_gutjnl-2026-338876v1.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205826","article-title":"Copy number variations and founder effect underlying complete IL-10R\u03b2 deficiency in Portuguese kindreds","volume":"13","author":"Charbit-Henrion","year":"2018","journal-title":"PLoS One"},{"key":"2026070810201532000_gutjnl-2026-338876v1.33","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-15-10","article-title":"Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease","volume":"15","author":"Frede","year":"2014","journal-title":"BMC Immunol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2026-338876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:20:30Z","timestamp":1783531230000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2026-338876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":33,"alternative-id":["10.1136\/gutjnl-2026-338876"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2026-338876","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}